Risk of using hydroxychloroquine as a treatment of COVID-19

The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Alanagreh, Lo’ai, Alzoughool, Foad, Atoum, Manar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Article Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504983/
https://www.ncbi.nlm.nih.gov/pubmed/32474476
http://dx.doi.org/10.3233/JRS-200024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504983/
https://www.ncbi.nlm.nih.gov/pubmed/32474476
http://dx.doi.org/10.3233/JRS-200024

Ejemplares similares